Generic Product Showcase-February 2015

Generic Supplements, Generic Supplement 2014, 0

Marketed by: Teva Pharmaceutical Industries, Ltd

Compare to: Exforge HCT Tablets (Novartis Pharmaceuticals)

Indication: Teva Pharmaceutical Industries, Ltd, has announced the launch of amlodipine, valsartan, and hydrochlorothiazide tablets, the generic equivalent of Exforge HCT tablets. Teva was first to file, making the product eligible for 180 days of marketing exclusivity. These fixed-combination tablets are available in 5 strengths and are indicated for second-line treatment of hypertension.

Dosage Form: Tablets: 5 mg/160 mg/12.5 mg, 5 mg/160 mg/25 mg, 10 mg/160 mg/12.5 mg, 10 mg/160 mg/25 mg, and 10 mg/320 mg/25 mg

For More Information: www.tevagenerics.com

Oxycodone Hydrochloride Tablets, USP (C-II)Marketed by: Amneal Pharmaceuticals, LLC

Compare to: Roxicodone (Mallinckrodt Inc)

Indication: Amneal Pharmaceuticals has announced the launch of oxycodone hydrochloride tablets, USP (C-II). The Amneal generic is AB-rated and therapeutically equivalent to Roxicodone. Oxycodone hydrochloride tablets, USP (C-II), are available in strengths of 5, 10, 15, 20, or 30 mg in 100-count bottles. It is indicated for the treatment of moderate to severe pain when the use of an opioid analgesic is appropriate.

Dosage Form: Tablets: 5, 10, 15, 20, or 30 mg

For More Information: www.amneal.com

Rizatriptan Immediate-Release TabletsMarketed by: Heritage Pharmaceuticals, Inc

Compare to: Maxalt (Merck)

Indication: Heritage Pharmaceuticals has announced the immediate availability of rizatriptan immediate-release tablets in 5- and 10-mg strengths. Rizatriptan is the AB-rated generic equivalent to the antimigraine drug Maxalt. It is indicated for the acute treatment of migraine, with or without aura, in adults and in pediatric patients aged 6 to 17 years. The package insert contains detailed information about the indications, side effects, and warnings.

Dosage Form: Tablets: 5 and 10 mg

For More Information: www.heritagepharma.com

Felodipine Extended-Release TabletsMarketed by: Heritage Pharmaceuticals, Inc

Compare to: Plendil (AstraZeneca)

Indication: Heritage Pharmaceuticals, Inc, has announced the immediate availability of felodipine extended-release tablets in 2.5-, 5-, and 10-mg strengths. Felodipine is the AB-rated generic equivalent of the calcium channel blocker drug Plendil. It is indicated for the treatment of hypertension. The package insert contains detailed information about the indications, side effects, and warnings.

Dosage Form: Tablets: 2.5, 5, and 10 mg

For More Information: www.heritagepharma.com